Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 04, 2019 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Receives Regional Award as 2018 Top Life Sciences Company

PARSIPPANY, NJ, March 04, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (IDXG) (“Interpace” or “the Company”) announced today that the Pittsburgh Business Times has designated Interpace...
February 28, 2019 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Announces Preliminary 2018 Revenues

Interpace to Host Fourth Quarter and Full Year 2018 Results Conference Call/Webcast PARSIPPANY, NJ, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG)...
February 19, 2019 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Announces First Independent Publication Demonstrating Clinical Utility of BarreGEN®

PARSIPPANY, NJ, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that BMJ Open Gastroenterology, an on-line, peer-reviewed, open access...
February 04, 2019 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics to Attend BIO CEO & Investor Conference in New York City

PARSIPPANY, NJ, Feb. 04, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group (NASDAQ: IDXG) today announced the Company will attend the 21st BIO CEO & Investor Conference being held in New...
January 29, 2019 16:20 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Announces Closing of $7.0 Million Public Offering of Common Stock

PARSIPPANY, N.J., Jan. 29, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (Nasdaq: IDXG) (“Interpace” or the “Company”) today announced the closing of its previously announced...
January 25, 2019 06:00 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Announces Pricing of $7.0 Million Public Offering of Common Stock

PARSIPPANY, N.J., Jan. 25, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (Nasdaq: IDXG) (“Interpace” or the “Company”) today announced the pricing of an underwritten public offering of...
January 24, 2019 16:35 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Announces Proposed Public Offering of Common Stock

PARSIPPANY, N.J., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (Nasdaq: IDXG) (“Interpace” or the “Company”) announced today that it intends to offer and sell shares of its...
January 24, 2019 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics to Present at the Fifteenth Annual NobleCon

PARSIPPANY, NJ, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group (NASDAQ: IDXG) today announced that Jack Stover, Chief Executive Officer, will present at NobleConXV - Noble Capital...
January 22, 2019 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Announces Further Expansion of Thyroid Business

Interpace Only Provider Validated to Offer MDx Tests on Three Distinct Platforms PARSIPPANY, NJ, Jan. 22, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (IDXG) announced today that it...
January 14, 2019 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Enters into Agreement with University of Maryland Medical System

Agreement Provides Access to Company’s Available Molecular Diagnostic Tests PARSIPPANY, NJ, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group (NASDAQ: IDXG) has entered in to an...